New drugs to overcome meccanisms of resistance in Ph+ leukemia: bosutinib. Hematology Meeting Reports, [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.722. Disponível em: https://journals.pagepress.net/hmr/article/view/722. Acesso em: 9 aug. 2026.